Last reviewed · How we verify

NCT05639985: Malnut-Reha

The Prevalence of Malnutrition and Sarcopenia in Swiss Rehabilitation Settings

Completed Last updated 25 April 2023
What this trial tests

trial in Malnutrition in 550 participants. Completed in 14 April 2023.

Timeline
1 November 2022
Primary endpoint
31 March 2023
14 April 2023

Quick facts

Lead sponsorUndine Lehmann, Dr.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment550
Start date1 November 2022
Primary completion31 March 2023
Estimated completion14 April 2023
Sites5 locations across Switzerland

Conditions studied

Sponsor

Undine Lehmann, Dr.

Who can join

18 and older, any sex, with Malnutrition or Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to identify the prevalence of malnutrition and sarcopenia in patients admitted in Swiss rehabilitation centers. Furthermore, the aim is to investigate the changes of selected malnutrition and sarcopenia parameters over the length of the rehabilitation stay.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Malnutrition and sarcopenia in inpatient rehabilitation: prevalence and associations with changes in bodyweight, muscle strength, and functional independence.
    Lehmann U, Uhlmann K, Meichtry A, Spielmanns M, et al · · 2025 · cited 7× · PMID 39998491 · DOI 10.2340/jrm.v57.42215

Verify or expand the search:

Other recruiting trials for Malnutrition

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05639985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing